Intervention Review

Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)

  1. Nicole Bergner1,
  2. Ina Monsef1,
  3. Gerald Illerhaus2,
  4. Andreas Engert1,
  5. Nicole Skoetz1,*

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 31 MAY 2012

DOI: 10.1002/14651858.CD009355.pub2


How to Cite

Bergner N, Monsef I, Illerhaus G, Engert A, Skoetz N. Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD009355. DOI: 10.1002/14651858.CD009355.pub2.

Author Information

  1. 1

    University Hospital of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

  2. 2

    University Hospital of Freiburg, Department I of Internal Medicine, Freiburg, Germany

*Nicole Skoetz, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. nicole.skoetz@uk-koeln.de.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.